<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet201633-8</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-7763</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзор литературы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Ожирение и когнитивная дисфункция</article-title><trans-title-group xml:lang="en"><trans-title>Obesity and cognitive dysfunction</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Матвеева</surname><given-names>Мария Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Matveeva</surname><given-names>Mariia Vladimirovna</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., врач-эндокринолог</p></bio><bio xml:lang="en"><p>PhD</p></bio><email xlink:type="simple">matveeva.mariia@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самойлова</surname><given-names>Юлия Геннадьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Samoylova</surname><given-names>Julia Gennadevna</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры эндокринологии и диабетологии</p></bio><bio xml:lang="en"><p>MD, PhD, prof.</p></bio><email xlink:type="simple">samoilova_y@inbox.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жукова</surname><given-names>Наталья Григорьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Zhukova</surname><given-names>Natalija Grigorevna</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры неврологии и нейрохирургии</p></bio><bio xml:lang="en"><p>MD, PhD, prof.</p></bio><email xlink:type="simple">znatali@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Общество с ограниченной ответственностью «Клиника МАММЭ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinic МАММE</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБОУ ВПО «Сибирский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sibirian State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>08</day><month>07</month><year>2016</year></pub-date><volume>13</volume><issue>3</issue><fpage>3</fpage><lpage>8</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Матвеева М.В., Самойлова Ю.Г., Жукова Н.Г., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Матвеева М.В., Самойлова Ю.Г., Жукова Н.Г.</copyright-holder><copyright-holder xml:lang="en">Matveeva M.V., Samoylova J.G., Zhukova N.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/7763">https://www.omet-endojournals.ru/jour/article/view/7763</self-uri><abstract><p>Ожирение принимает масштабы эпидемии, охватывая различные группы населения. В свою очередь, цереброваскулярная патология занимает одну из лидирующих позиций в спектре неврологических расстройств. Исследователи указывают на роль ожирения в развитии когнитивных нарушений. Однако клеточные и биохимические механизмы, лежащие в основе такой связи, остаются малоизученными. Кроме того, несмотря на очевидную ассоциацию ожирения с ухудшением умственной деятельности, продемонстрированную в клинических исследованиях, долгое время оставалось неясным, вызваны ли эти нарушения ожирением как таковым или связанными с ним состояниями, такими как метаболический синдром, сахарный диабет или сердечно-сосудистые заболевания. В настоящее время в отечественной литературе отсутствуют систематизированные данные о причинно-следственных связях этих двух патологий.</p></abstract><trans-abstract xml:lang="en"><p>Obesity takes epidemic proportions, encompassing different groups of society. In turn, cerebrovascular pathology holds a leading position in the spectrum of neurological disorders. Researchers indicate a role of obesity in the development of cognitive impairment. However, the cellular and biochemical mechanisms underlying that connection are still poorly understood. In addition, despite the obvious association of obesity with the deterioration of mental activity demonstrated in clinical trials for a long time it was unclear whether these disorders are caused by obesity per se or related conditions, such as metabolic syndrome, diabetes or cardiovascular disease. Currently there is scarse systematic data on a cause-effect relationships of these two pathologies.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>когнитивная дисфункция</kwd><kwd>лепти</kwd><kwd>инсулинорезистентность</kwd><kwd>гипертриглицеридемия</kwd><kwd>воспаление</kwd><kwd>дисбактериоз</kwd><kwd>генетика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>cognitive dysfunction</kwd><kwd>leptin</kwd><kwd>insulin resistance</kwd><kwd>hypertriglyceridemia</kwd><kwd>inflammation</kwd><kwd>dysbacteriosis</kwd><kwd>genetics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ожирение и избыточный вес. Информационный бюллетень N311. [Электронный ресурс] [Obesity and overweight Fact sheet N311. (In Russ.)] Доступно по: http://www.who.int/mediacentre/factsheets/fs311/ru/. Ссылка активна на 30.09.2016.</mixed-citation><mixed-citation xml:lang="en">Ожирение и избыточный вес. Информационный бюллетень N311. [Электронный ресурс] [Obesity and overweight Fact sheet N311. (In Russ.)] Доступно по: http://www.who.int/mediacentre/factsheets/fs311/ru/. Ссылка активна на 30.09.2016.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Yaffe K, Weston AL, Blackwell T, Krueger KA. The Metabolic Syndrome and Development of Cognitive Impairment Among Older Women. Arch Neurol. 2009;66(3). doi: 10.1001/archneurol.2008.566.</mixed-citation><mixed-citation xml:lang="en">Yaffe K, Weston AL, Blackwell T, Krueger KA. The Metabolic Syndrome and Development of Cognitive Impairment Among Older Women. Arch Neurol. 2009;66(3). doi: 10.1001/archneurol.2008.566.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Танашян М.М., Лагода О.В., Орлов С.В., и др. Сосудистые заболевания головного мозга и метаболический синдром // Терапевтический архив. – 2013. – Т.85. – №10. – С. 34-42. [Tanash’yan MM, Lagoda OV, Orlov SV, et al. Sosudistye zabolevaniya golovnogo mozga i metabolicheskiy sindrom. Terapevticheskiy arkhiv. 2013;85(10):34-42. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Танашян М.М., Лагода О.В., Орлов С.В., и др. Сосудистые заболевания головного мозга и метаболический синдром // Терапевтический архив. – 2013. – Т.85. – №10. – С. 34-42. [Tanash’yan MM, Lagoda OV, Orlov SV, et al. Sosudistye zabolevaniya golovnogo mozga i metabolicheskiy sindrom. Terapevticheskiy arkhiv. 2013;85(10):34-42. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hanning CD. Postoperative cognitive dysfunction. British journal of anaesthesia. 2005;95(1):82–87.</mixed-citation><mixed-citation xml:lang="en">Hanning CD. Postoperative cognitive dysfunction. British journal of anaesthesia. 2005;95(1):82–87.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Незнанов Н.Г., Пиотровская В.Р., Ванаева К.И., и др. Результаты скрининговой оценки когнитивных функций у лиц с избыточной массой тела. // Артериальная гипертензия. – 2011. – Т.17. - №2. – С.156-161. [Neznanov NG, Piotrovskaya VR, Vanaeva KI, et al. Rezul’taty skriningovoy otsenki kognitivnykh funktsiy u lits s izbytochnoy massoy tela. Arterial’naya gipertenziya. 2011; 17(2):156-161. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Незнанов Н.Г., Пиотровская В.Р., Ванаева К.И., и др. Результаты скрининговой оценки когнитивных функций у лиц с избыточной массой тела. // Артериальная гипертензия. – 2011. – Т.17. - №2. – С.156-161. [Neznanov NG, Piotrovskaya VR, Vanaeva KI, et al. Rezul’taty skriningovoy otsenki kognitivnykh funktsiy u lits s izbytochnoy massoy tela. Arterial’naya gipertenziya. 2011; 17(2):156-161. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Суханов А.В., Денисова Д.В. Ассоциация массы тела с состоянием когнитивных функций в подростковом возрасте: популяционное исследование. // Журнал им. Г.Н. Сперанского. – 2011. –Т.90. -№6. –С.26-28. [Sukhanov AV, Denisova DV. Assotsiatsiya massy tela s sostoyaniem kognitivnykh funktsiy v podrostkovom vozraste: populyatsionnoe issledovanie. Zhurnal im. G.N. Speranskogo. 2011;90(6):26-28. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Суханов А.В., Денисова Д.В. Ассоциация массы тела с состоянием когнитивных функций в подростковом возрасте: популяционное исследование. // Журнал им. Г.Н. Сперанского. – 2011. –Т.90. -№6. –С.26-28. [Sukhanov AV, Denisova DV. Assotsiatsiya massy tela s sostoyaniem kognitivnykh funktsiy v podrostkovom vozraste: populyatsionnoe issledovanie. Zhurnal im. G.N. Speranskogo. 2011;90(6):26-28. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bolzenius JD, Laidlaw DH, Cabeen RP, et al. Brain structure and cognitive correlates of body mass index in healthy older adults. Behav Brain Res. 2015;278:342-347. doi: 10.1016/j.bbr.2014.10.010.</mixed-citation><mixed-citation xml:lang="en">Bolzenius JD, Laidlaw DH, Cabeen RP, et al. Brain structure and cognitive correlates of body mass index in healthy older adults. Behav Brain Res. 2015;278:342-347. doi: 10.1016/j.bbr.2014.10.010.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Яхно Н.Н., Захаров В.В., Локшина А.Б., и др. Деменции. Руководство для врачей. – М.: МЕДпресс-информ; 2011 [Yakhno NN, Zakharov VV, Lokshina AB, et al. Dementsii. Rukovodstvo dlya vrachey. Moscow: MEDpress-inform; 2011. (In Russ).]</mixed-citation><mixed-citation xml:lang="en">Яхно Н.Н., Захаров В.В., Локшина А.Б., и др. Деменции. Руководство для врачей. – М.: МЕДпресс-информ; 2011 [Yakhno NN, Zakharov VV, Lokshina AB, et al. Dementsii. Rukovodstvo dlya vrachey. Moscow: MEDpress-inform; 2011. (In Russ).]</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Xie Z, Tanzi RE. Alzheimer’s disease and post-operative cognitive dysfunction. Experimental gerontology. 2006;41(4):346–359.</mixed-citation><mixed-citation xml:lang="en">Xie Z, Tanzi RE. Alzheimer’s disease and post-operative cognitive dysfunction. Experimental gerontology. 2006;41(4):346–359.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lovenstone S, Gauthier S. Management of dementia. London: Martin Dunitz, 2001.</mixed-citation><mixed-citation xml:lang="en">Lovenstone S, Gauthier S. Management of dementia. London: Martin Dunitz, 2001.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Folch J, Pedros I, Patraca I, et al. Neuroprotective and anti-ageing role of leptin. J Mol Endocrinol. 2012;49(3):R149-R156. doi: 10.1530/jme-12-0151.</mixed-citation><mixed-citation xml:lang="en">Folch J, Pedros I, Patraca I, et al. Neuroprotective and anti-ageing role of leptin. J Mol Endocrinol. 2012;49(3):R149-R156. doi: 10.1530/jme-12-0151.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zeki Al Hazzouri A, Haan MN, Whitmer RA, et al. Central Obesity, Leptin and Cognitive Decline: The Sacramento Area Latino Study on Aging. Dement Geriatr Cogn Disord. 2012;33(6):400-409. doi: 10.1159/000339957.</mixed-citation><mixed-citation xml:lang="en">Zeki Al Hazzouri A, Haan MN, Whitmer RA, et al. Central Obesity, Leptin and Cognitive Decline: The Sacramento Area Latino Study on Aging. Dement Geriatr Cogn Disord. 2012;33(6):400-409. doi: 10.1159/000339957.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Farr OM, Tsoukas MA, Mantzoros CS. Leptin and the brain: Influences on brain development, cognitive functioning and psychiatric disorders. Metabolism. 2015;64(1):114-130. doi: 10.1016/j.metabol.2014.07.004.</mixed-citation><mixed-citation xml:lang="en">Farr OM, Tsoukas MA, Mantzoros CS. Leptin and the brain: Influences on brain development, cognitive functioning and psychiatric disorders. Metabolism. 2015;64(1):114-130. doi: 10.1016/j.metabol.2014.07.004.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Li XL, Aou S, Oomura Y, et al. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience. 2002;113(3):607-615. doi: 10.1016/s0306-4522(02)00162-8.</mixed-citation><mixed-citation xml:lang="en">Li XL, Aou S, Oomura Y, et al. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience. 2002;113(3):607-615. doi: 10.1016/s0306-4522(02)00162-8.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kamal A, Biessels GJ, Urban IJA, Gispen WH. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience. 1999;90(3):737-745. doi: 10.1016/s0306-4522(98)00485-0.</mixed-citation><mixed-citation xml:lang="en">Kamal A, Biessels GJ, Urban IJA, Gispen WH. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience. 1999;90(3):737-745. doi: 10.1016/s0306-4522(98)00485-0.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Schrijvers EMC, Witteman JCM, Sijbrands EJG, et al. Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study. Neurology. 2010;75(22):1982-1987. doi: 10.1212/WNL.0b013e3181ffe4f6.</mixed-citation><mixed-citation xml:lang="en">Schrijvers EMC, Witteman JCM, Sijbrands EJG, et al. Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study. Neurology. 2010;75(22):1982-1987. doi: 10.1212/WNL.0b013e3181ffe4f6.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pratchayasakul W, Sa-nguanmoo P, Sivasinprasasn S, et al. Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions. Horm Behav. 2015;72:68-77. doi: 10.1016/j.yhbeh.2015.04.023.</mixed-citation><mixed-citation xml:lang="en">Pratchayasakul W, Sa-nguanmoo P, Sivasinprasasn S, et al. Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions. Horm Behav. 2015;72:68-77. doi: 10.1016/j.yhbeh.2015.04.023.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cetinkalp S, Simsir I, Ertek S. Insulin Resistance in Brain and Possible Therapeutic Approaches. Curr Vasc Pharmacol. 2014;12(4):553-564. doi: 10.2174/1570161112999140206130426.</mixed-citation><mixed-citation xml:lang="en">Cetinkalp S, Simsir I, Ertek S. Insulin Resistance in Brain and Possible Therapeutic Approaches. Curr Vasc Pharmacol. 2014;12(4):553-564. doi: 10.2174/1570161112999140206130426.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J, Freire D, Knable L, et al. Childhood and adolescent obesity and long-term cognitive consequences during aging. J Comp Neurol. 2015;523(5):757-768. doi: 10.1002/cne.23708.</mixed-citation><mixed-citation xml:lang="en">Wang J, Freire D, Knable L, et al. Childhood and adolescent obesity and long-term cognitive consequences during aging. J Comp Neurol. 2015;523(5):757-768. doi: 10.1002/cne.23708.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Biessels GJ, Reagan LP. Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience. 2015;16(11):660-671. doi: 10.1038/nrn4019.</mixed-citation><mixed-citation xml:lang="en">Biessels GJ, Reagan LP. Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience. 2015;16(11):660-671. doi: 10.1038/nrn4019.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sasaki-Hamada S, Hojo Y, Koyama H, et al. Changes in hippocampal synaptic functions and protein expression in monosodium glutamate-treated obese mice during development of glucose intolerance. Eur J Neurosci. 2015;41(11):1393-1401. doi: 10.1111/ejn.12891.</mixed-citation><mixed-citation xml:lang="en">Sasaki-Hamada S, Hojo Y, Koyama H, et al. Changes in hippocampal synaptic functions and protein expression in monosodium glutamate-treated obese mice during development of glucose intolerance. Eur J Neurosci. 2015;41(11):1393-1401. doi: 10.1111/ejn.12891.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Awad N, Gagnon M, Messier C. The Relationship between Impaired Glucose Tolerance, Type 2 Diabetes, and Cognitive Function. J Clin Exp Neuropsychol. 2004;26(8):1044-1080. doi: 10.1080/13803390490514875.</mixed-citation><mixed-citation xml:lang="en">Awad N, Gagnon M, Messier C. The Relationship between Impaired Glucose Tolerance, Type 2 Diabetes, and Cognitive Function. J Clin Exp Neuropsychol. 2004;26(8):1044-1080. doi: 10.1080/13803390490514875.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Дубина Е.А., Ротарь О.П., Могучая Е.В., и др. Метаболический синдром и когнитивная дисфункция у лиц пожилого возраста: женщины – группа риска // Артериальная гипертензия. – 2014. – Т. 20. - № 4. – С. 238-248. [Dubina EA, Rotar’ OP, Moguchaya EV, et al. Metabolicheskiy sindrom i kognitivnaya disfunktsiya u lits pozhilogo vozrasta: zhenshchiny – gruppa riska. Arterial’naya gipertenziya. 2014;20(4):238-248. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Дубина Е.А., Ротарь О.П., Могучая Е.В., и др. Метаболический синдром и когнитивная дисфункция у лиц пожилого возраста: женщины – группа риска // Артериальная гипертензия. – 2014. – Т. 20. - № 4. – С. 238-248. [Dubina EA, Rotar’ OP, Moguchaya EV, et al. Metabolicheskiy sindrom i kognitivnaya disfunktsiya u lits pozhilogo vozrasta: zhenshchiny – gruppa riska. Arterial’naya gipertenziya. 2014;20(4):238-248. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Morley JE, Banks WA. Lipids and cognition. J Alzheimers Dis. 2010; 20(3):737-47. doi: 10.3233/JAD-2010-091576.</mixed-citation><mixed-citation xml:lang="en">Morley JE, Banks WA. Lipids and cognition. J Alzheimers Dis. 2010; 20(3):737-47. doi: 10.3233/JAD-2010-091576.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Sims-Robinson C, Bakeman A, Rosko A, et al. The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain. Mol Neurobiol. 2016;53(4):2287-2296.</mixed-citation><mixed-citation xml:lang="en">Sims-Robinson C, Bakeman A, Rosko A, et al. The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain. Mol Neurobiol. 2016;53(4):2287-2296.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Farr SA, Yamada KA, Butterfield DA, et al. Obesity and Hypertriglyceridemia Produce Cognitive Impairment. Endocrinology. 2008;149(5):2628-2636. doi: 10.1210/en.2007-1722.</mixed-citation><mixed-citation xml:lang="en">Farr SA, Yamada KA, Butterfield DA, et al. Obesity and Hypertriglyceridemia Produce Cognitive Impairment. Endocrinology. 2008;149(5):2628-2636. doi: 10.1210/en.2007-1722.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ефимова Н.Ю., Чернов В.И., Ефимова И.Ю., и др. Роль дисфункции эндотелия в механизме развития когнитивных нарушений у пациентов с метаболическим синдромом. // Сибирский вестник психиатрии и наркологии. – 2010. – Т. 2. – № 59. С.85-89. [Efimova NY, Chernov VI, Efimova IY, et al. Rol’ disfunktsii endoteliya v mekhanizme razvitiya kognitivnykh narusheniy u patsientov s metabolicheskim sindromom. Sibirskiy vestnik psikhiatrii i narkologii. 2010; 2 (59):85-89. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Ефимова Н.Ю., Чернов В.И., Ефимова И.Ю., и др. Роль дисфункции эндотелия в механизме развития когнитивных нарушений у пациентов с метаболическим синдромом. // Сибирский вестник психиатрии и наркологии. – 2010. – Т. 2. – № 59. С.85-89. [Efimova NY, Chernov VI, Efimova IY, et al. Rol’ disfunktsii endoteliya v mekhanizme razvitiya kognitivnykh narusheniy u patsientov s metabolicheskim sindromom. Sibirskiy vestnik psikhiatrii i narkologii. 2010; 2 (59):85-89. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Shishkova VN. Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: possibility for correction and prevention. (in Russ). Terapevticheskii arkhiv. 2014; 87(1):109-14.</mixed-citation><mixed-citation xml:lang="en">Shishkova VN. Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: possibility for correction and prevention. (in Russ). Terapevticheskii arkhiv. 2014; 87(1):109-14.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dorrance AM, Matin N, Pires PW. The effects of obesity on the cerebral vasculature. Curr Vasc Pharmacol. 2014;12(3):462-72.</mixed-citation><mixed-citation xml:lang="en">Dorrance AM, Matin N, Pires PW. The effects of obesity on the cerebral vasculature. Curr Vasc Pharmacol. 2014;12(3):462-72.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Miller AA, Spencer SJ. Obesity and neuroinflammation: A pathway to cognitive impairment. Brain Behav Immun. 2014;42:10-21. doi: 10.1016/j.bbi.2014.04.001.</mixed-citation><mixed-citation xml:lang="en">Miller AA, Spencer SJ. Obesity and neuroinflammation: A pathway to cognitive impairment. Brain Behav Immun. 2014;42:10-21. doi: 10.1016/j.bbi.2014.04.001.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Stranahan AM. Models and mechanisms for hippocampal dysfunction in obesity and diabetes. Neuroscience. 2015;309:125-139. doi: 10.1016/j.neuroscience.2015.04.045.</mixed-citation><mixed-citation xml:lang="en">Stranahan AM. Models and mechanisms for hippocampal dysfunction in obesity and diabetes. Neuroscience. 2015;309:125-139. doi: 10.1016/j.neuroscience.2015.04.045.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Puig J, Blasco G, Daunis-i-Estadella J, et al. Hypothalamic Damage Is Associated With Inflammatory Markers and Worse Cognitive Performance in Obese Subjects. J Clin Endocrinol Metab. 2015;100(2):E276-E281. doi: 10.1210/jc.2014-2682.</mixed-citation><mixed-citation xml:lang="en">Puig J, Blasco G, Daunis-i-Estadella J, et al. Hypothalamic Damage Is Associated With Inflammatory Markers and Worse Cognitive Performance in Obese Subjects. J Clin Endocrinol Metab. 2015;100(2):E276-E281. doi: 10.1210/jc.2014-2682.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Spyridaki EC, Simos P, Avgoustinaki PD, et al. The association between obesity and fluid intelligence impairment is mediated by chronic low-grade inflammation. Br J Nutr. 2014;112(10):1724-1734. doi: 10.1017/s0007114514002207.</mixed-citation><mixed-citation xml:lang="en">Spyridaki EC, Simos P, Avgoustinaki PD, et al. The association between obesity and fluid intelligence impairment is mediated by chronic low-grade inflammation. Br J Nutr. 2014;112(10):1724-1734. doi: 10.1017/s0007114514002207.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Thaler JP, Yi C-X, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 2012;122(1):153-162. doi: 10.1172/jci59660.</mixed-citation><mixed-citation xml:lang="en">Thaler JP, Yi C-X, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 2012;122(1):153-162. doi: 10.1172/jci59660.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ramakrishna BS. Role of the gut microbiota in human nutrition and metabolism. J Gastroenterol Hepatol. 2013;28:9-17. doi: 10.1111/jgh.12294.</mixed-citation><mixed-citation xml:lang="en">Ramakrishna BS. Role of the gut microbiota in human nutrition and metabolism. J Gastroenterol Hepatol. 2013;28:9-17. doi: 10.1111/jgh.12294.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Bruce-Keller AJ, Salbaum JM, Luo M, et al. Obese-type Gut Microbiota Induce Neurobehavioral Changes in the Absence of Obesity. Biol Psychiatry. 2015;77(7):607-615. doi: 10.1016/j.biopsych.2014.07.012.</mixed-citation><mixed-citation xml:lang="en">Bruce-Keller AJ, Salbaum JM, Luo M, et al. Obese-type Gut Microbiota Induce Neurobehavioral Changes in the Absence of Obesity. Biol Psychiatry. 2015;77(7):607-615. doi: 10.1016/j.biopsych.2014.07.012.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Kang SS, Jeraldo PR, Kurti A, et al. Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition. Mol Neurodegener. 2014;9(1):36. doi: 10.1186/1750-1326-9-36.</mixed-citation><mixed-citation xml:lang="en">Kang SS, Jeraldo PR, Kurti A, et al. Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition. Mol Neurodegener. 2014;9(1):36. doi: 10.1186/1750-1326-9-36.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Зуева И.Б., Морошкина Н.В., Улитина А.С., и др. Влияние аллельных вариантов гена NGF (полиморфизм rs6330) на развитие когнитивного дефицита у больных с метаболическим синдромом. // Вестник Российской военно-медицинской академии. – 2013. – № 1 (прил.41). – С. 59-64. [Zueva IB, Moroshkina NV, Ulitina AS, et al. Vliyanie allel’nykh variantov gena NGF (polimorfizm rs6330) na razvitie kognitivnogo defitsita u bol’nykh s metabolicheskim sindromom. Vestnik Rossiyskoy voenno-meditsinskoy akademii. 2013;1(suppl.41):59 – 64. (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Зуева И.Б., Морошкина Н.В., Улитина А.С., и др. Влияние аллельных вариантов гена NGF (полиморфизм rs6330) на развитие когнитивного дефицита у больных с метаболическим синдромом. // Вестник Российской военно-медицинской академии. – 2013. – № 1 (прил.41). – С. 59-64. [Zueva IB, Moroshkina NV, Ulitina AS, et al. Vliyanie allel’nykh variantov gena NGF (polimorfizm rs6330) na razvitie kognitivnogo defitsita u bol’nykh s metabolicheskim sindromom. Vestnik Rossiyskoy voenno-meditsinskoy akademii. 2013;1(suppl.41):59 – 64. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Alosco ML, Benitez A, Gunstad J, et al. Reduced memory in fat mass and obesity-associated allele carriers among older adults with cardiovascular disease. Psychogeriatrics. 2013;13(1):35-40. doi: 10.1111/j.1479-8301.2012.00424.x.</mixed-citation><mixed-citation xml:lang="en">Alosco ML, Benitez A, Gunstad J, et al. Reduced memory in fat mass and obesity-associated allele carriers among older adults with cardiovascular disease. Psychogeriatrics. 2013;13(1):35-40. doi: 10.1111/j.1479-8301.2012.00424.x.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Benedict C, Jacobsson JA, Rönnemaa E, et al. The fat mass and obesity gene is linked to reduced verbal fluency in overweight and obese elderly men. Neurobiol Aging. 2011;32(6):1159.e1151-1159.e1155. doi: 10.1016/j.neurobiolaging.2011.02.006.</mixed-citation><mixed-citation xml:lang="en">Benedict C, Jacobsson JA, Rönnemaa E, et al. The fat mass and obesity gene is linked to reduced verbal fluency in overweight and obese elderly men. Neurobiol Aging. 2011;32(6):1159.e1151-1159.e1155. doi: 10.1016/j.neurobiolaging.2011.02.006.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Robinson L, McKillop-Smith S, Ross NL, et al. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats. Psychopharmacology (Berl). 2008. 198. 551-563</mixed-citation><mixed-citation xml:lang="en">Robinson L, McKillop-Smith S, Ross NL, et al. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats. Psychopharmacology (Berl). 2008. 198. 551-563</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Зуева И.Б., Ванаева К.И. Эндогенные канабиоиды и когнитивные функции у пациентов с ожирением. // Бюллетень со РАМН. – 2012. – Т.32. – № 5. С.63-68. [Zueva IB, Vanaeva KI. Endogennye kanabioidy i kognitivnye funktsii u patsientov s ozhireniem. Bulletin of RAMS. 2012;32(5):63-68 (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Зуева И.Б., Ванаева К.И. Эндогенные канабиоиды и когнитивные функции у пациентов с ожирением. // Бюллетень со РАМН. – 2012. – Т.32. – № 5. С.63-68. [Zueva IB, Vanaeva KI. Endogennye kanabioidy i kognitivnye funktsii u patsientov s ozhireniem. Bulletin of RAMS. 2012;32(5):63-68 (In Russ.)].</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
